Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas
- PMID: 37310089
- DOI: 10.14670/HH-18-634
Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas
Abstract
Oral squamous cell carcinoma (OSCC) is the most common oral malignancy, representing 90% of all malignant neoplasms in the head and neck region. Patients with this aggressive tumor have an overall 5-year survival rate of approximately 50%, which drops to less than 30% when tumors are diagnosed at advanced clinical stages. Over decades, several studies provided high-level evidence of the impact of histopathological features on treatment guidelines and prognosis of OSCC. The 8th American Joint Committee on Cancer (AJCC) TNM staging system recognized the importance of depth of invasion to the T category and extranodal extension to the N category for OSCC. This review provides the current knowledge on emerging histopathological parameters identified as potential biomarkers for OSCC, such as depth of invasion, tumor thickness, the pattern of invasion, inflammatory profile, and tumor-stroma ratio, evaluating their clinical relevance on patient outcomes. Analysis, limitations, and potential biological mechanisms are highlighted and discussed. Assessing and reporting these markers are cost-effective and can be incorporated into daily practice.
©The Author(s) 2024. Open Access. This article is licensed under a Creative Commons CC-BY International License.
Similar articles
-
Prognosis of oral cancer: a comparison of the staging systems given in the 7th and 8th editions of the American Joint Committee on Cancer Staging Manual.Br J Oral Maxillofac Surg. 2018 Jan;56(1):8-13. doi: 10.1016/j.bjoms.2017.11.009. Epub 2017 Nov 29. Br J Oral Maxillofac Surg. 2018. PMID: 29198482
-
Comparison of the 8th edition of TNM staging of oral cancer with the 7th edition and its prognostic significance using clinical depth of invasion and extranodal extension.Oral Oncol. 2023 Oct;145:106519. doi: 10.1016/j.oraloncology.2023.106519. Epub 2023 Jul 16. Oral Oncol. 2023. PMID: 37459802
-
Evaluating depth of invasion across oral cavity subsites as part of the AJCC 8th edition T staging criteria for oral cavity squamous cell carcinoma.Head Neck. 2023 Nov;45(11):2780-2788. doi: 10.1002/hed.27497. Epub 2023 Sep 12. Head Neck. 2023. PMID: 37698539
-
Management of Stage III Oral Cavity Squamous Cell Carcinoma in Light of the New Staging System: a Critical Review.Curr Oncol Rep. 2023 Feb;25(2):107-113. doi: 10.1007/s11912-022-01353-6. Epub 2022 Dec 31. Curr Oncol Rep. 2023. PMID: 36585962 Review.
-
Risk stratification in oral squamous cell carcinoma using staging of the eighth American Joint Committee on Cancer: Systematic review and meta-analysis.Head Neck. 2020 Oct;42(10):3002-3017. doi: 10.1002/hed.26344. Epub 2020 Jun 17. Head Neck. 2020. PMID: 32548858
Cited by
-
Understanding the role of nerves in head and neck cancers - a review.Oncol Rev. 2025 Jan 20;18:1514004. doi: 10.3389/or.2024.1514004. eCollection 2024. Oncol Rev. 2025. PMID: 39906323 Free PMC article. Review.
-
CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance.Mol Cancer. 2025 Jan 31;24(1):36. doi: 10.1186/s12943-025-02239-4. Mol Cancer. 2025. PMID: 39891203 Free PMC article.
-
Prognostic significance of preoperative Naples prognostic score for disease-free and overall survival in oral cavity squamous cell carcinoma post-surgery.BMC Cancer. 2025 Apr 22;25(1):757. doi: 10.1186/s12885-025-14146-4. BMC Cancer. 2025. PMID: 40264051 Free PMC article.
-
Predicting Early Death in Head and Neck Cancer-A Pilot Study.Cancers (Basel). 2025 Jan 17;17(2):302. doi: 10.3390/cancers17020302. Cancers (Basel). 2025. PMID: 39858084 Free PMC article.
-
Correlation between Histopathological Features and Clinical Outcomes in Patients with Oral Squamous Cell Carcinoma.J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S433-S435. doi: 10.4103/jpbs.jpbs_1442_24. Epub 2025 Feb 25. J Pharm Bioallied Sci. 2025. PMID: 40511045 Free PMC article.
References
-
- Almangush A., Bello I.O., Keski-Säntti H., Mäkinen L.K., Kauppila J.H., Pukkila M., Hagström J., Laranne J., Tommola S., Nieminen O., Soini Y., Kosma V. M., Koivunen P., Grénman R., Leivo I. and Salo T. (2014). Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early-stage oral tongue cancer. Head Neck 36, 811-818 - PMC - PubMed
-
- Almangush A., Coletta R.D., Bello I.O., Bitu C., Keski-Säntti H., Mäkinen L.K., Kauppila J.H., Pukkila M., Hagström J., Laranne J., Tommola S., Soini Y., Kosma V.M., Koivunen P., Kowalski L.P., Nieminen P., Grénman R., Leivo I. and Salo T. (2015). A simple novel prognostic model for early stage oral tongue cancer. Int. J. Oral. Maxillofac. Surg. 44, 143-150. - PubMed
-
- Almangush A., Mäkitie A.A., Mäkinen LK., Kauppila J.H., Pukkila M., Hagström J., Laranne J., Soini Y., Kowalski L.P., Grénman R., Haglund C., Coletta R.D., Salo T. and Leivo I. (2018a). Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer. Virchows Arch. 473, 481-487. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical